Because insurance coverage and treatment eligibility can vary, some individuals choose to work with telehealth weight management programs that connect patients with licensed healthcare providers who can evaluate whether GLP-1 medications such as Ozempic or semaglutide may be appropriate
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimers Trial Novo Nordisk, the drugmaker behind Wegovy and Ozempic, took a longshot gamble, and lost
I went to the hospital and was in the ICU for five days
These medications can help by: Reducing appetite and cravings Slowing digestion so you feel full longer Improving insulin response and blood sugar regulation Supporting more consistent energy and fewer hunger spikes Eligibility depends on your medical history, current medications, and goals
IBX, the largest insurer in southeastern Pennsylvania, will continue to cover these medications when they are prescribed for people with conditions approved by the Food and Drug Administration, such as Type 2 diabetes and cardiovascular disease